Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	B:C1654920
Stenting	I:C1654920
for	O
Cancer	O
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	O
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	O
Cancer	O
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	O
.	O

Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	O
Stenting	I:C1654920
for	O
Cancer	B:C0152018
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	O
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	O
Cancer	O
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	O
.	O

Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	O
Stenting	I:C1654920
for	O
Cancer	O
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	B:C0020023
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	O
Cancer	O
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	O
.	O

Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	O
Stenting	I:C1654920
for	O
Cancer	O
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	O
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	B:C0021201
Cancer	O
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	O
.	O

Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	O
Stenting	I:C1654920
for	O
Cancer	O
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	O
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	O
Cancer	B:C0152018
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	O
.	O

Long	O
Term	O
Outcome	O
in	O
Patients	O
with	O
Esophageal	O
Stenting	I:C1654920
for	O
Cancer	O
Esophagus	I:C0152018
-	O
Our	O
Experience	O
at	O
a	O
Rural	O
Hospital	I:C0020023
of	O
Punjab	O
,	O
India	O
Cancer	O
of	I:C0152018
the	I:C0152018
esophagus	I:C0152018
is	O
among	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
in	O
Punjab	O
,	O
India	B:C0021201
.	O

Patients	O
generally	O
present	B:C0150312
with	O
dysphagia	O
as	O
their	O
first	O
symptom	O
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	O
of	O
presentation	O
to	O
a	O
tertiary	O
care	I:C0587437
centre	I:C0587437
.	O

Patients	O
generally	O
present	O
with	O
dysphagia	B:C0011168
as	O
their	O
first	O
symptom	O
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	O
of	O
presentation	O
to	O
a	O
tertiary	O
care	I:C0587437
centre	I:C0587437
.	O

Patients	O
generally	O
present	O
with	O
dysphagia	O
as	O
their	O
first	O
symptom	B:C1457887
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	O
of	O
presentation	O
to	O
a	O
tertiary	O
care	I:C0587437
centre	I:C0587437
.	O

Patients	O
generally	O
present	O
with	O
dysphagia	O
as	O
their	O
first	O
symptom	O
and	O
more	O
often	O
they	O
have	O
advanced	O
disease	O
at	O
the	O
time	O
of	O
presentation	O
to	O
a	O
tertiary	B:C0587437
care	I:C0587437
centre	I:C0587437
.	O

Palliative	B:C1285158
procedures	I:C1285158
have	O
important	O
roles	O
in	O
this	O
setting	O
.	O

Stenting	B:C2348535
is	O
the	O
best	O
option	O
to	O
palliate	O
the	O
symptoms	O
of	O
dysphagia	O
,	O
from	O
which	O
patient	O
is	O
suffering	O
the	I:C0518881
most	I:C0518881
.	O

Stenting	O
is	O
the	O
best	O
option	O
to	O
palliate	O
the	O
symptoms	B:C1457887
of	O
dysphagia	O
,	O
from	O
which	O
patient	O
is	O
suffering	O
the	I:C0518881
most	I:C0518881
.	O

Stenting	O
is	O
the	O
best	O
option	O
to	O
palliate	O
the	O
symptoms	O
of	O
dysphagia	B:C0011168
,	O
from	O
which	O
patient	O
is	O
suffering	O
the	I:C0518881
most	I:C0518881
.	O

Stenting	O
is	O
the	O
best	O
option	O
to	O
palliate	O
the	O
symptoms	O
of	O
dysphagia	O
,	O
from	O
which	O
patient	O
is	O
suffering	B:C0518881
the	I:C0518881
most	I:C0518881
.	O

To	O
know	O
the	O
success	O
rate	O
,	O
early	B:C0231243
and	O
long	O
term	O
complications	O
and	O
mortality	O
in	O
esophageal	O
stenting	I:C1654920
,	O
when	O
it	O
was	O
done	O
in	O
malignant	O
esophageal	I:C0341129
stricture	I:C0341129
patients	O
.	O

To	O
know	O
the	O
success	O
rate	O
,	O
early	O
and	O
long	O
term	O
complications	B:C0009566
and	O
mortality	O
in	O
esophageal	O
stenting	I:C1654920
,	O
when	O
it	O
was	O
done	O
in	O
malignant	O
esophageal	I:C0341129
stricture	I:C0341129
patients	O
.	O

To	O
know	O
the	O
success	O
rate	O
,	O
early	O
and	O
long	O
term	O
complications	O
and	O
mortality	O
in	O
esophageal	B:C1654920
stenting	I:C1654920
,	O
when	O
it	O
was	O
done	O
in	O
malignant	O
esophageal	I:C0341129
stricture	I:C0341129
patients	O
.	O

To	O
know	O
the	O
success	O
rate	O
,	O
early	O
and	O
long	O
term	O
complications	O
and	O
mortality	O
in	O
esophageal	O
stenting	I:C1654920
,	O
when	O
it	O
was	O
done	O
in	O
malignant	B:C0341129
esophageal	I:C0341129
stricture	I:C0341129
patients	O
.	O

One	O
hundred	O
patients	O
,	O
who	O
had	O
undergone	O
esophageal	B:C1654920
stenting	I:C1654920
from	O
January	O
2012	O
to	O
January	O
2015	O
,	O
were	O
included	O
in	O
the	O
study	O
.	O

One	O
hundred	O
patients	O
,	O
who	O
had	O
undergone	O
esophageal	O
stenting	I:C1654920
from	O
January	O
2012	O
to	O
January	O
2015	O
,	O
were	O
included	O
in	O
the	O
study	B:C2603343
.	O

We	O
retrospectively	B:C0035363
analysed	I:C0035363
the	O
data	O
for	O
patient	O
characteristics	O
,	O
causes	O
of	O
non-operability	O
,	O
early	O
and	O
long	O
term	O
complications	O
,	O
re-interventions	O
,	O
efficacy	O
and	O
mortality	O
.	O

We	O
retrospectively	O
analysed	I:C0035363
the	O
data	O
for	O
patient	O
characteristics	O
,	O
causes	O
of	O
non-operability	O
,	O
early	B:C0231243
and	O
long	O
term	O
complications	O
,	O
re-interventions	O
,	O
efficacy	O
and	O
mortality	O
.	O

We	O
retrospectively	O
analysed	I:C0035363
the	O
data	O
for	O
patient	O
characteristics	O
,	O
causes	O
of	O
non-operability	O
,	O
early	O
and	O
long	O
term	O
complications	B:C0009566
,	O
re-interventions	O
,	O
efficacy	O
and	O
mortality	O
.	O

We	O
retrospectively	O
analysed	I:C0035363
the	O
data	O
for	O
patient	O
characteristics	O
,	O
causes	O
of	O
non-operability	O
,	O
early	O
and	O
long	O
term	O
complications	O
,	O
re-interventions	B:C0184661
,	O
efficacy	O
and	O
mortality	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	B:C2348535
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	O
(	O
52	O
%	O
)	O
,	O
metastatic	O
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	O
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	O
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	O
in	O
5	O
%	O
of	O
patients	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	O
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	B:C0543467
(	O
52	O
%	O
)	O
,	O
metastatic	O
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	O
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	O
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	O
in	O
5	O
%	O
of	O
patients	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	O
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	O
(	O
52	O
%	O
)	O
,	O
metastatic	B:C2939420
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	O
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	O
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	O
in	O
5	O
%	O
of	O
patients	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	O
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	O
(	O
52	O
%	O
)	O
,	O
metastatic	O
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	B:C0038454
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	O
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	O
in	O
5	O
%	O
of	O
patients	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	O
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	O
(	O
52	O
%	O
)	O
,	O
metastatic	O
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	O
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	B:C1659989
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	O
in	O
5	O
%	O
of	O
patients	O
.	O

Out	O
of	O
100	O
patients	O
,	O
indications	O
for	O
stenting	O
were	O
locally	O
advanced	O
disease	O
not	O
amenable	O
to	O
surgery	O
(	O
52	O
%	O
)	O
,	O
metastatic	O
disease	I:C2939420
(	O
35	O
%	O
)	O
,	O
CVA	O
(	O
1	O
%	O
)	O
,	O
cardiac	O
and	O
respiratory	O
problem	I:C1659989
(	O
8	O
%	O
)	O
,	O
un	O
-willing	O
for	O
surgery	B:C0543467
in	O
5	O
%	O
of	O
patients	O
.	O

Majority	O
of	O
patients	O
(	O
94	O
%	O
)	O
had	O
squamous	B:C0007137
cell	I:C0007137
carcinoma	I:C0007137
,	O
while	O
only	O
6	O
%	O
had	O
adenocarcinoma	O
.	O

Majority	O
of	O
patients	O
(	O
94	O
%	O
)	O
had	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
,	O
while	O
only	O
6	O
%	O
had	O
adenocarcinoma	B:C0001418
.	O

84	O
%	O
of	O
patients	O
presented	O
with	O
dysphagia	B:C0011168
with	O
or	O
without	O
chest	O
pain	I:C0008031
and	O
recurrent	O
cough	I:C3553459
while	O
16	O
%	O
had	O
recurrent	O
vomiting	I:C0750325
.	O

84	O
%	O
of	O
patients	O
presented	O
with	O
dysphagia	O
with	O
or	O
without	O
chest	B:C0008031
pain	I:C0008031
and	O
recurrent	O
cough	I:C3553459
while	O
16	O
%	O
had	O
recurrent	O
vomiting	I:C0750325
.	O

84	O
%	O
of	O
patients	O
presented	O
with	O
dysphagia	O
with	O
or	O
without	O
chest	O
pain	I:C0008031
and	O
recurrent	B:C3553459
cough	I:C3553459
while	O
16	O
%	O
had	O
recurrent	O
vomiting	I:C0750325
.	O

84	O
%	O
of	O
patients	O
presented	O
with	O
dysphagia	O
with	O
or	O
without	O
chest	O
pain	I:C0008031
and	O
recurrent	O
cough	I:C3553459
while	O
16	O
%	O
had	O
recurrent	B:C0750325
vomiting	I:C0750325
.	O

58	O
%	O
had	O
dysphagia	B:C0011168
to	O
liquids	O
and	O
solids	O
and	O
17	O
%	O
had	O
complete	O
dysphagia	I:C0011168
.	O

58	O
%	O
had	O
dysphagia	O
to	O
liquids	O
and	O
solids	O
and	O
17	O
%	O
had	O
complete	B:C0011168
dysphagia	I:C0011168
.	O

After	O
stenting	B:C2348535
93	O
%	O
had	O
significant	O
improvement	O
in	O
dysphagia	O
score	O
from	O
median	O
of	O
3	O
to	O
1	O
.	O

After	O
stenting	O
93	O
%	O
had	O
significant	O
improvement	O
in	O
dysphagia	B:C0011168
score	O
from	O
median	O
of	O
3	O
to	O
1	O
.	O

One	O
patient	O
had	O
procedure	B:C0184661
related	O
major	O
complication	O
in	O
the	O
form	O
of	O
post	O
procedural	I:C0919874
bleed	I:C0919874
(	O
after	O
16	O
days	O
of	O
stenting	O
)	O
leading	O
to	O
death	O
of	O
that	O
patient	O
.	O

One	O
patient	O
had	O
procedure	O
related	O
major	O
complication	B:C0009566
in	O
the	O
form	O
of	O
post	O
procedural	I:C0919874
bleed	I:C0919874
(	O
after	O
16	O
days	O
of	O
stenting	O
)	O
leading	O
to	O
death	O
of	O
that	O
patient	O
.	O

One	O
patient	O
had	O
procedure	O
related	O
major	O
complication	O
in	O
the	O
form	O
of	O
post	B:C0919874
procedural	I:C0919874
bleed	I:C0919874
(	O
after	O
16	O
days	O
of	O
stenting	O
)	O
leading	O
to	O
death	O
of	O
that	O
patient	O
.	O

One	O
patient	O
had	O
procedure	O
related	O
major	O
complication	O
in	O
the	O
form	O
of	O
post	O
procedural	I:C0919874
bleed	I:C0919874
(	O
after	O
16	O
days	O
of	O
stenting	B:C2348535
)	O
leading	O
to	O
death	O
of	O
that	O
patient	O
.	O

One	O
patient	O
had	O
procedure	O
related	O
major	O
complication	O
in	O
the	O
form	O
of	O
post	O
procedural	I:C0919874
bleed	I:C0919874
(	O
after	O
16	O
days	O
of	O
stenting	O
)	O
leading	O
to	O
death	B:C1306577
of	O
that	O
patient	O
.	O

Minor	B:C0558080
complications	O
were	O
present	O
in	O
52	O
patients	O
treated	O
conservatively	O
not	O
affecting	O
the	O
efficacy	O
of	O
procedure	O
.	O

Minor	O
complications	B:C0009566
were	O
present	O
in	O
52	O
patients	O
treated	O
conservatively	O
not	O
affecting	O
the	O
efficacy	O
of	O
procedure	O
.	O

Minor	O
complications	O
were	O
present	B:C0150312
in	O
52	O
patients	O
treated	O
conservatively	O
not	O
affecting	O
the	O
efficacy	O
of	O
procedure	O
.	O

Minor	O
complications	O
were	O
present	O
in	O
52	O
patients	O
treated	O
conservatively	O
not	O
affecting	O
the	O
efficacy	O
of	O
procedure	B:C0184661
.	O

These	O
include	O
pain	B:C0030193
after	O
stenting	O
(	O
38	O
%	O
)	O
,	O
stent	O
obstruction	I:C0028778
(	O
23	O
%	O
)	O
and	O
stent	O
migration	I:C4087543
(	O
6	O
%	O
)	O
.	O

These	O
include	O
pain	O
after	O
stenting	B:C2348535
(	O
38	O
%	O
)	O
,	O
stent	O
obstruction	I:C0028778
(	O
23	O
%	O
)	O
and	O
stent	O
migration	I:C4087543
(	O
6	O
%	O
)	O
.	O

These	O
include	O
pain	O
after	O
stenting	O
(	O
38	O
%	O
)	O
,	O
stent	B:C0028778
obstruction	I:C0028778
(	O
23	O
%	O
)	O
and	O
stent	O
migration	I:C4087543
(	O
6	O
%	O
)	O
.	O

These	O
include	O
pain	O
after	O
stenting	O
(	O
38	O
%	O
)	O
,	O
stent	O
obstruction	I:C0028778
(	O
23	O
%	O
)	O
and	O
stent	B:C4087543
migration	I:C4087543
(	O
6	O
%	O
)	O
.	O

All	O
the	O
minor	B:C0558080
complications	O
were	O
treated	O
conservatively	O
except	O
in	O
six	O
patients	O
in	O
whom	O
re-stenting	O
was	O
done	O
.	O

All	O
the	O
minor	O
complications	B:C0009566
were	O
treated	O
conservatively	O
except	O
in	O
six	O
patients	O
in	O
whom	O
re-stenting	O
was	O
done	O
.	O

All	O
the	O
minor	O
complications	O
were	O
treated	O
conservatively	O
except	O
in	O
six	O
patients	O
in	O
whom	O
re-stenting	B:C2348535
was	O
done	O
.	O

Esophageal	B:C1654920
stenting	I:C1654920
is	O
relatively	O
safe	O
procedure	O
with	O
short	O
stay	O
of	O
the	O
patient	O
in	O
the	O
hospital	O
.	O

Esophageal	O
stenting	I:C1654920
is	O
relatively	O
safe	O
procedure	B:C0184661
with	O
short	O
stay	O
of	O
the	O
patient	O
in	O
the	O
hospital	O
.	O

Esophageal	O
stenting	I:C1654920
is	O
relatively	O
safe	O
procedure	O
with	O
short	O
stay	O
of	O
the	O
patient	O
in	O
the	O
hospital	B:C0019994
.	O

Although	O
,	O
it	O
helps	O
in	O
alleviating	O
patients	O
'	O
morbidity	O
very	O
effectively	O
and	O
reliably	O
,	O
there	O
are	O
many	O
technical	O
glitches	O
,	O
which	O
needs	O
to	O
be	O
kept	O
into	O
account	O
and	O
patient	O
should	O
be	O
properly	O
counseled	B:C0600047
before	O
the	O
procedure	O
to	O
prevent	O
and	O
manage	O
post	O
procedure	O
complications	O
and	O
medico	O
legal	O
aspects	O
.	O

Although	O
,	O
it	O
helps	O
in	O
alleviating	O
patients	O
'	O
morbidity	O
very	O
effectively	O
and	O
reliably	O
,	O
there	O
are	O
many	O
technical	O
glitches	O
,	O
which	O
needs	O
to	O
be	O
kept	O
into	O
account	O
and	O
patient	O
should	O
be	O
properly	O
counseled	O
before	O
the	O
procedure	B:C0184661
to	O
prevent	O
and	O
manage	O
post	O
procedure	O
complications	O
and	O
medico	O
legal	O
aspects	O
.	O

Although	O
,	O
it	O
helps	O
in	O
alleviating	O
patients	O
'	O
morbidity	O
very	O
effectively	O
and	O
reliably	O
,	O
there	O
are	O
many	O
technical	O
glitches	O
,	O
which	O
needs	O
to	O
be	O
kept	O
into	O
account	O
and	O
patient	O
should	O
be	O
properly	O
counseled	O
before	O
the	O
procedure	O
to	O
prevent	O
and	O
manage	O
post	O
procedure	O
complications	B:C0009566
and	O
medico	O
legal	O
aspects	O
.	O

